Skip to main content
. Author manuscript; available in PMC: 2021 Apr 9.
Published in final edited form as: J Allergy Clin Immunol. 2016 Aug 20;139(1):152–165. doi: 10.1016/j.jaci.2016.07.019

Table 2.

Comparison of ichthyosis patients vs. healthy controls and subjects with AD or psoriasis.

Comparison of ichthyosis patients vs. healthy controls and subjects with AD or psoriasis.

Characteristic Parameter Controls (n=16) Ichthyosis (n=21; LS=21) P-value Controls vs. Ichthyosis AD (n=16; LS=16; NL=16) PSO (n=10; LS=10; NL=10) P-value All groups
Age (years) Mean (±SD) 38.7 ± 17.1 26.8 ± 14.6 0.033 52.8 ± 13.1 51.3 ± 11.0 < 0.001
Median [age range] 44.5 [10.6–57] 23.0 [10.8–57] 49.5 [33–73] 54.0 [30–64]

Gender Female 7 13 0.444 8 4 0.609
Male 9 8 8 6

Race White 13 17 0.269 16 10 0.201
Black 0 2 0 0
Asian 0 1 0 0
Hispanic 3 1 0 0

Disease Severity Scores IASI SCORAD PASI
Mean (±SD) N/A 28.9 ± 9.0 56.6 ± 10.7 20.3 ± 15.4
Median [IQR] N/A 29.7 [21.2 – 36.0] 55.0 [51.5 – 63.0] 14.2 [12.1 – 21.2]

AD: atopic dermatitis; CIE: congenital ichthyosiform erythroderma; EI: erythrodermic ichthyosis; NS: Netherton syndrome; IASI: ichthyosis area severity index (with E: erythema; S: scaling); LI: lamellar ichthyosis; LS: lesionai; N/A: not applicable. NL: non- lesional; PASI: psoriasis area severity index; PSO: psoriasis; SCORAD: scoring atopic dermatitis; SD: standard deviation; TEWL: transepidermal water loss.